A novel heterozygous mutation in the glucokinase gene is responsible for an early-onset mild form of maturity-onset diabetes of the young, type 2

被引:3
作者
Papadimitriou, D. T. [1 ,5 ]
Willems, P. J. [2 ]
Bothou, C. [3 ]
Karpathios, T. [4 ]
Papadimitriou, A. [5 ]
机构
[1] Athens Med Ctr, Dept Paediat Adolescent Endocrinol & Diabet, Athens, Greece
[2] Genet Diagnost Network GENDIA, Antwerp, Belgium
[3] Univ Athens, Sch Med, GR-11527 Athens, Greece
[4] Athens Med Ctr, Dept Pediat, Athens, Greece
[5] Attikon Univ Hosp, Pediat Endocrine Unit, Dept Pediat 3, Athens, Greece
关键词
Anti-GAD antibodies; Glucokinase; Hyperglycaemia; Maturity-onset diabetes of the young; MODY; MODY;
D O I
10.1016/j.diabet.2015.03.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:342 / 343
页数:2
相关论文
共 10 条
[1]  
American Diabetes Association, 2014, DIABETES CARE S1, V37, P53
[2]   Clinical Heterogeneity in Monogenic Diabetes Caused by Mutations in the Glucokinase Gene (GCK-MODY) [J].
Cuesta-Munoz, Antonio L. ;
Tuomi, Tiinamaija ;
Cobo-Vuilleumier, Nadia ;
Koskela, Hanna ;
Odili, Stella ;
Stride, Amanda ;
Buettger, Carol ;
Otonkoski, Timo ;
Froguel, Philippe ;
Grimsby, Joseph ;
Garcia-Gimeno, Maria ;
Matschinsky, Franz M. .
DIABETES CARE, 2010, 33 (02) :290-292
[3]   Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young [J].
Ellard, S. ;
Bellanne-Chantelot, C. ;
Hattersley, A. T. .
DIABETOLOGIA, 2008, 51 (04) :546-553
[4]   Clinical features and treatment of maturity onset diabetes of the young (MODY) [J].
Gardner, Daphne S. L. ;
Tai, E. Shyong .
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2012, 5 :101-108
[5]   Glucokinase (GCK) mutations in hyper- and hypoglycemia:: Maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy [J].
Gloyn, AL .
HUMAN MUTATION, 2003, 22 (05) :353-362
[6]   Update on Mutations in Glucokinase (GCK), Which Cause Maturity-Onset Diabetes of the Young, Permanent Neonatal Diabetes, and Hyperinsulinemic Hypoglycemia [J].
Osbak, Kara K. ;
Colclough, Kevin ;
Saint-Martin, Cecile ;
Beer, Nicola L. ;
Bellanne-Chantelot, Christine ;
Ellard, Sian ;
Gloyn, Anna L. .
HUMAN MUTATION, 2009, 30 (11) :1512-1526
[7]   Negativation of type 1 diabetes-associated autoantibodies to glutamic acid decarboxylase and insulin in children treated with oral calcitriol [J].
Papadimitriou, Dimitrios T. ;
Marakaki, Chrisanthi ;
Fretzayas, Andreas ;
Nicolaidou, Polyxeni ;
Papadimitriou, Anastasios .
JOURNAL OF DIABETES, 2013, 5 (03) :344-348
[8]   Maturity-onset diabetes of the young (MODY): how many cases are we missing? [J].
Shields, B. M. ;
Hicks, S. ;
Shepherd, M. H. ;
Colclough, K. ;
Hattersley, A. T. ;
Ellard, S. .
DIABETOLOGIA, 2010, 53 (12) :2504-2508
[9]   Screening for MODY mutations, GAD antibodies, and type 1 diabetes-associated HLA genotypes in women with gestational diabetes mellitus [J].
Weng, JP ;
Ekelund, M ;
Lehto, M ;
Li, HY ;
Ekberg, G ;
Frid, A ;
Åberg, A ;
Groop, LC ;
Berntorp, K .
DIABETES CARE, 2002, 25 (01) :68-71
[10]   Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes - The 2-year analysis of the German BABYDIAB study [J].
Ziegler, AG ;
Hummel, M ;
Schenker, M ;
Bonifacio, E .
DIABETES, 1999, 48 (03) :460-468